Digestive Enzymes: A Science-Backed Formulation Guide for Supplement Brands

This is part of Ingredient Intelligence, a series tracking where the supplement market is going and what it means for your next SKU.

---

Digestion is one of the body’s most fundamental functions and one of its most chemically complex. Before nutrients can be absorbed, food must be broken into smaller components. Stomach acid, bile, and digestive enzymes work together to convert carbohydrates into simple sugars, proteins into amino acids, and fats into fatty acids and glycerol.

For supplement brands, that makes digestive enzymes an intuitive product opportunity, and a natural next stop in our Ingredient Intelligence series on where the market is heading. But developing a differentiated, science-backed digestive enzyme supplement requires more than assembling a long list of enzymes.

The most effective formulation strategy starts with three questions:

• What substrate is the product designed to help digest?
• Where in the gastrointestinal tract does the enzyme need to work?
• Does the formula deliver enough measurable enzyme activity under the intended use conditions?

Lactase, for example, has a well-defined role when lactose digestion is the objective, and NIDDK notes that lactase products can help some people manage the symptoms that follow. Alpha-galactosidase can help break down certain fermentable carbohydrates before they reach the colon, an effect that has also been studied in people sensitive to galacto-oligosaccharides. Broad-spectrum formulas may support digestion across mixed meals, but the evidence depends on the specific enzymes, activities, doses, and formulation.

For product development teams, the opportunity is not simply to add more enzymes. It is to build a formula in which enzyme selection, activity, delivery, substantiation, and consumer positioning all reinforce one another.

How Digestive Enzymes Work

Digestion is a coordinated system rather than the work of a single enzyme.

The process begins in the mouth, where salivary enzymes start breaking down starches. In the stomach, acid and enzymes contribute to protein digestion. The pancreas then provides enzymes that help break down carbohydrates, fats, and proteins in the small intestine, while bile supports the digestion of fats. Most nutrient absorption also occurs in the small intestine.

The large intestine plays a different role. Microorganisms in the gut can break down material that escapes digestion and absorption earlier in the gastrointestinal tract.

That distinction is important when developing products for the broader digestive health category.

Digestive enzymes primarily act on food substrates. Probiotics, prebiotics, and postbiotics interact with the microbial ecosystem through different mechanisms. These approaches can be complementary in a comprehensive gut-health platform, and brands building a combined strategy can look to our guide on prebiotic, probiotic, and postbiotic formulation for how to combine them without treating enzymes and biotics as interchangeable.

For brands exploring digestive health innovation, clearly defining each ingredient’s role can lead to a more credible formula and a more understandable consumer story.

The Digestive Enzyme Map: Matching the Enzyme to the Substrate

A useful way to evaluate an enzyme formulation is to connect each enzyme to the substrate it acts upon and the use occasion the finished product is intended to address.

Enzyme	Primary Substrate	Potential Product Positioning	Formulation Consideration
Amylase	Starches and complex carbohydrates	Mixed-meal or carbohydrate digestion	Supplemental value should be evaluated within the context of the complete enzyme system.
Protease	Proteins and peptides	Protein-containing meals	Performance depends on protease type, activity, pH profile, dose, and the rest of the blend.
Lipase	Dietary fats	Mixed meals containing fats	General digestive supplementation should remain clearly distinct from medical pancreatic enzyme replacement therapy, which is used to manage exocrine pancreatic insufficiency.
Lactase	Lactose	Dairy digestion	One of the clearest substrate-specific opportunities. NIDDK notes that lactase products can help some people manage symptoms associated with lactose intolerance.
Alpha-galactosidase	Certain alpha-galactoside oligosaccharides	Beans, legumes, and other selected fermentable foods	Human studies show benefits in some populations and meal settings, but outcomes are not universal.
AN-PEP	Proline-rich gluten peptides	Digestion of small, incidental amounts of gluten	Human evidence demonstrates gluten degradation, but it must not be positioned as protection for people with celiac disease, which FDA treats as a disease claim rather than a structure/function claim.

The product-development implication is straightforward: start with the intended use occasion and work backward to the enzyme system, rather than starting with the number of enzymes that can fit on a Supplement Facts panel.

Lactase: A Clear Example of Substrate-Specific Formulation

Lactose digestion provides one of the clearest examples of how targeted enzyme supplementation can work.

Lactose must be broken down by lactase before its components can be efficiently absorbed. When lactase activity is reduced, undigested lactose may reach the colon and contribute to gastrointestinal symptoms in susceptible individuals.

The potential audience is significant. According to the National Institute of Diabetes and Digestive and Kidney Diseases, approximately 68% of the global population has lactose malabsorption, although lactose malabsorption and symptomatic lactose intolerance are not the same condition.

This distinction creates a more precise product-development opportunity.

Instead of positioning dairy itself as problematic, or suggesting that everyone needs supplemental lactase, a brand can develop a targeted formula designed to help digest lactose in dairy-containing foods. NIDDK notes that lactase tablets may be taken before consuming milk products and lactase drops can be added to milk to break down lactose.

For a brand manager evaluating a dairy-digestion concept, this specificity can make the product easier to merchandise, easier to communicate, and easier to substantiate than a generic “digestive support” formula.

Alpha-Galactosidase: Addressing Fermentable Carbohydrates Upstream

Beans, legumes, and other plant foods can contain oligosaccharides that are not fully digested in the small intestine. When these compounds reach the colon, bacteria ferment them. This is a normal process, but it can also generate gas.

Alpha-galactosidase is designed to begin breaking down certain of these carbohydrates before they reach the colon.

In a randomized, double-blind, placebo-controlled study involving a bean-rich test meal, alpha-galactosidase reduced breath hydrogen and flatulence severity at the study’s higher tested activity level. Another controlled study involving people with IBS who were sensitive to galacto-oligosaccharides found that full-dose alpha-galactosidase reduced overall symptoms and bloating.

However, the evidence is not completely uniform. A later crossover pilot study did not find alpha-galactosidase superior to placebo for post-meal symptoms or breath hydrogen and methane in its study population.

For product developers, that inconsistency is instructive.

A biologically plausible mechanism does not automatically support a broad claim across every population. The more defensible approach is to develop and substantiate the product around a specific substrate and use occasion, rather than positioning an enzyme as a universal answer to gastrointestinal symptoms.

Broad-Spectrum Digestive Enzyme Blends: Formulate With Purpose

Most meals contain multiple macronutrients at the same time. That explains why broad-spectrum digestive enzyme products frequently combine amylases, proteases, lipases, lactase, and additional carbohydrases.

The formulation logic is straightforward: different enzymes address different substrates.

But brands should be cautious about assuming that evidence for the category automatically substantiates any individual blend.

A 2023 randomized, double-blind, placebo-controlled trial evaluated a specific fungal-derived multi-enzyme preparation in 120 adults with functional dyspepsia. Participants receiving the enzyme preparation experienced improvements in study measures compared with placebo.

That study provides evidence for the specific formulation that was tested. It does not mean every broad-spectrum digestive enzyme blend will produce the same results.

For formulation and regulatory teams, the distinction matters:

The ingredient panel itself is not the substantiation.

Instead, evaluate:

• The specific enzymes selected
• Activity supplied per serving
• Relevant pH activity
• Finished-product stability
• Intended timing of use
• Human evidence supporting the enzyme system or ingredient
• Whether proposed structure/function claims accurately reflect that evidence

This evidence-led approach can help brands develop products that are both more differentiated and easier to defend.

Why Enzyme Activity Matters More Than Milligrams

One of the most important considerations in digestive enzyme formulation is also one of the easiest to overlook: enzyme potency cannot be evaluated by weight alone.

For many vitamins and minerals, milligrams or micrograms provide an immediate indication of the quantity present. Enzymes work differently because their functional value comes from catalytic activity.

The Food Chemicals Codex describes enzyme activity according to the reaction catalyzed by the enzyme, with activity generally expressed in defined units relative to the enzyme preparation. FDA guidance also emphasizes defined enzyme activity and recognized analytical methods.

As a result, two formulations containing the same milligram weight of an enzyme blend can potentially provide substantially different enzymatic activity.

When qualifying an enzyme ingredient or reviewing a finished formula, product-development teams should ask:

• Which activity unit is being used for each enzyme?
• What analytical assay defines that activity?
• At what pH and temperature is activity measured?
• Is activity guaranteed only for the incoming ingredient or also considered through finished-product shelf life?
• Can the enzyme remain active where it needs to function in the digestive tract?
• Will the suggested serving timing allow the enzyme to encounter its intended food substrate?

These questions can be more meaningful than simply comparing the milligram totals of competing enzyme blends.

pH, Timing, and Stability Can Change the Formula Story

The gastrointestinal tract is not a uniform environment.

An enzyme may encounter the acidic conditions of the stomach before entering the substantially different environment of the small intestine. An enzyme demonstrating strong activity under laboratory conditions may therefore perform differently if its activity profile does not match the conditions in which it encounters its intended substrate.

Gluten-targeting enzymes provide a useful example. Research comparing commercial digestive enzymes indicates that DPP-IV and Aspergillus niger prolyl endoprotease, or AN-PEP, differ in their mechanisms and activity profiles. AN-PEP is active under acidic gastric conditions and acts on proline-rich peptides, while DPP-IV functions differently.

Timing also matters.

Lactase, for example, is taken before dairy products so the enzyme can encounter lactose during digestion. The same product-development logic applies to broader formulations: directions for use should support the conditions under which the enzyme system has been designed and evaluated to perform.

Stability adds another dimension. Processing conditions, temperature, moisture, packaging, and storage can all influence enzyme activity.

For brands, that makes enzyme formulation an end-to-end manufacturing challenge, not simply an ingredient-selection exercise.

Gluten-Digesting Enzymes: An Area Where Claim Discipline Is Essential

Gluten-targeting enzymes illustrate why mechanistic science and consumer-facing claims must remain carefully separated.

Among food-grade enzyme approaches studied in humans is AN-PEP. In a 2017 randomized, placebo-controlled crossover trial involving self-reported gluten-sensitive adults consuming a meal containing 0.5 grams of gluten, both tested AN-PEP doses substantially reduced gluten concentrations in the stomach and duodenum. The higher dose reduced stomach gluten exposure by approximately 88% and duodenal exposure by approximately 56% compared with placebo.

Those results demonstrate gluten degradation under the conditions of that study.

They do not demonstrate that an enzyme prevents intestinal injury associated with celiac disease or makes gluten-containing foods safe for individuals with celiac disease. The study authors specifically positioned the enzyme as a potential aid for small, unintended gluten exposure rather than a replacement for a gluten-free diet.

Research evaluating commercially available digestive enzyme supplements has also found substantial differences in their ability to break down immunogenic gluten epitopes.

The Claim Guardrail

A formulation designed to help digest gluten presents a fundamentally different regulatory proposition than a product that implies it can protect someone with celiac disease.

FDA distinguishes permissible dietary supplement structure/function claims from claims to diagnose, mitigate, treat, cure, or prevent disease.

For brands developing gluten-focused digestive enzymes, ingredient characterization, substantiation, label language, and marketing review should therefore be aligned from the beginning, not addressed only after formulation is complete.

Build the Product Around the Use Occasion

The strongest digestive enzyme concepts typically begin with a defined consumer need rather than an oversized enzyme panel.

Everyday Mixed-Meal Support

Potential enzyme strategy: Amylase + protease + lipase, with additional carbohydrases where justified

Positioning: Helps support digestion of carbohydrates, proteins, and fats.

Development priority: Establish meaningful activity specifications and evaluate evidence that supports the complete formulation rather than relying only on the presence of familiar enzyme categories.

Dairy Digestion

Potential enzyme strategy: Lactase

Positioning: Helps digest lactose in dairy foods.

Development priority: Keep the story substrate-specific. Lactose intolerance and milk allergy involve different biological mechanisms and should never be treated as interchangeable.

Plant-Forward Meal Support

Potential enzyme strategy: Alpha-galactosidase

Positioning: Helps break down selected fermentable carbohydrates found in foods such as beans and legumes.

Development priority: Match the positioning to available evidence and avoid turning targeted meal support into a universal gastrointestinal symptom claim.

Gluten-Aware Digestive Support

Potential enzyme strategy: A clinically characterized enzyme such as AN-PEP

Positioning: Helps break down small amounts of gluten under substantiated conditions.

Development priority: Maintain strict claim boundaries. The product must not imply that it makes gluten safe for people with celiac disease or replaces a gluten-free diet, which would cross from a structure/function claim into a disease claim.

Complete Gut-Health Platform

Potential strategy: Targeted digestive enzymes combined with selected prebiotic, probiotic, or postbiotic ingredients

Positioning: Supports different aspects of digestive and gut health through clearly defined mechanisms.

Development priority: Give every ingredient a reason to be in the formula. Enzymes and biotics should complement one another rather than being combined simply to make the ingredient panel appear more complex, particularly since prebiotic ingredients support digestion through mechanisms distinct from enzymatic breakdown.

For brands, each concept creates a different formulation, substantiation, merchandising, and communication strategy.

Precision Can Be More Powerful Than the “Kitchen Sink”

Digestive enzyme products have historically been easy to differentiate on quantity: more enzymes, more ingredients, more substrates, more claims.

But quantity is not necessarily the best indicator of formulation quality.

A stronger product story makes it clear:

1. What food substrate the formula is designed to address
2. Why the selected enzyme is appropriate for that substrate
3. How meaningful activity is defined and measured
4. When the product should be used
5. What the available evidence does and does not support

That discipline can also open clearer innovation paths.

A dairy-focused product may be built around meaningful lactase activity rather than an unnecessarily complicated multi-enzyme blend. A plant-forward concept may focus on alpha-galactosidase. A premium everyday digestive product can use a purposeful broad-spectrum system supported by activity specifications and stability considerations.

For Product Development teams, this approach reduces formulation ambiguity and gives a contract supplement manufacturer a clear specification to hold through production. For Brand and Category Managers, it creates a clearer proposition that can stand apart on shelf.

What This Means for Dietary Supplement Brands

Deciding what an enzyme formula is actually for commits a brand to a specification it has to hold through shelf life and a claim it has to defend. Here are the most important considerations for your brand:

Formulation: Enzyme potency cannot be evaluated by weight alone, because an enzyme’s functional value comes from catalytic activity rather than mass, and two formulas carrying the same milligram weight of a blend can provide substantially different activity. A usable specification names the activity unit, the assay that defines it, and whether that activity is guaranteed only for the incoming ingredient or through finished-product shelf life, which makes an enzyme formula an end-to-end manufacturing question rather than an ingredient-selection one.

Regulatory and Claims: Evidence for a tested formulation is not evidence for a category, and the ingredient panel itself is not the substantiation. A formula designed to help digest gluten and one implying protection for someone with celiac disease are fundamentally different regulatory propositions, because FDA separates permissible structure/function claims from claims to diagnose, mitigate, treat, cure, or prevent disease. Ingredient characterization, label language, and marketing review belong in the formulation brief from the beginning, not after it is complete.

Competitive Positioning: This category has historically been easy to differentiate on quantity: more enzymes, more ingredients, more substrates, more claims. Quantity is not necessarily the best indicator of formulation quality, and the narrower formula is often the more defensible one, whether that is a dairy product built around meaningful lactase activity instead of a complicated multi-enzyme blend or a plant-forward concept focused on alpha-galactosidase.

Turning an enzyme concept into a commercially successful supplement requires coordinating R&D, sourcing, quality, manufacturing, regulatory review, and packaging, so choosing a manufacturing partner has to look past whether it can simply source the enzymes named on a specification sheet. Important capabilities include:

• Formulation expertise: The ability to match enzyme systems to the intended substrate, dosage form, and positioning.
• Ingredient sourcing: Access to well-characterized enzyme ingredients with appropriate identity, activity, safety, and technical documentation, the kind of enzyme sourcing and activity verification built into the manufacturing process itself.
• Activity-focused specifications: Naming the activity unit and the assay used to verify it, held through finished-product shelf life rather than only at intake.
• Quality systems: Rigorous testing, documentation, and GMP-aligned manufacturing controls.
• Finished-product expertise: Accounting for how processing, temperature, moisture, packaging, and storage can move that activity number.
• Regulatory awareness: Support for building substantiated structure/function positioning without crossing into disease claims.
• Scalable production: The ability to move efficiently from development through commercial-scale manufacturing as demand grows.

Activity specifications, claim boundaries, and a defined use occasion are one decision rather than three, and dietary supplement contract manufacturing is where a formula that treated them separately comes apart.

Frequently Asked Questions About Digestive Enzyme Formulation

The Takeaway for Supplement Brands

Digestive enzymes create an intuitive connection between ingredient science and a specific consumer use occasion. But the strongest products move beyond generic “digestive support” toward substrate-specific, activity-defined, and evidence-led formulation.

For product-development teams, that means considering activity units, pH profile, timing, stability, sourcing, and substantiation from the beginning.

For brand teams, it means building a proposition that consumers can understand quickly: a defined enzyme, doing a defined job, for a defined use occasion.

And for both teams, precision creates an advantage. A purposeful formula is easier to explain, easier to differentiate, and easier to support with credible science, particularly when it comes from turnkey supplement manufacturing that keeps formulation, sourcing, and substantiation connected.

^†These statements have not been evaluated by The Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.